Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.

Featured Stories

IP Forecast: Cooley Atty Faces DQ Bid Over Past Patent Work No Photo Available

A prominent Cooley LLP lawyer will face questions next week in a Philadelphia courtroom over her work a decade ago at her former firm ... (more story)

Justices Hand Abortion Advocates An Incomplete Win No Photo Available

The U.S. Supreme Court's rejection Thursday of a challenge to the abortion drug mifepristone will do little to safeguard long-term acc... (more story)

Thomas Targets Group Standing In Mifepristone Ruling No Photo Available

U.S. Supreme Court Justice Clarence Thomas joined his colleagues Thursday to unanimously uphold broad access to the abortion medicatio... (more story)